Combination treatment with highly bioavailable curcumin and NQO1 inhibitor exhibits potent antitumor effects on esophageal squamous cell carcinoma.

Ayaka MizumotoShinya OhashiMayumi KamadaTomoki SaitoYukie NakaiKiichiro BabaKenshiro HirohashiYosuke MitaniOsamu KikuchiJunichi MatsubaraAtsushi YamadaTsukasa TakahashiHyunjin LeeYasushi OkunoMasashi KanaiManabu Muto

Published in: Journal of gastroenterology (2019)

These findings suggest the potential usefulness of THC and its combination with NQO1 inhibitor as a therapeutic option for ESCC.

Keyphrases

human health
risk assessment
combination therapy
climate change